Crescent Sterling Ltd. lowered its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 3.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,362 shares of the company’s stock after selling 786 shares during the quarter. Procter & Gamble comprises approximately 3.8% of Crescent Sterling Ltd.’s investment portfolio, making the stock its 5th biggest position. Crescent Sterling Ltd.’s holdings in Procter & Gamble were worth $3,749,000 as of its most recent SEC filing.
A number of other hedge funds have also recently added to or reduced their stakes in PG. Acorn Creek Capital LLC grew its stake in shares of Procter & Gamble by 2.8% during the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after purchasing an additional 59 shares during the period. Patrick M Sweeney & Associates Inc. grew its position in Procter & Gamble by 1.1% during the third quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after buying an additional 59 shares during the period. Traveka Wealth LLC increased its holdings in Procter & Gamble by 1.7% during the third quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after buying an additional 60 shares during the last quarter. Allen Mooney & Barnes Investment Advisors LLC raised its position in Procter & Gamble by 0.7% in the third quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company’s stock worth $1,507,000 after acquiring an additional 61 shares during the period. Finally, Valued Wealth Advisors LLC boosted its stake in shares of Procter & Gamble by 11.2% during the 3rd quarter. Valued Wealth Advisors LLC now owns 605 shares of the company’s stock worth $105,000 after acquiring an additional 61 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Performance
Procter & Gamble stock opened at $158.73 on Monday. The company’s 50-day moving average price is $169.64 and its 200-day moving average price is $169.61. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The company has a market cap of $373.82 billion, a PE ratio of 27.37, a price-to-earnings-growth ratio of 3.70 and a beta of 0.45. The Procter & Gamble Company has a twelve month low of $146.28 and a twelve month high of $180.43.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on PG shares. DA Davidson reissued a “buy” rating and issued a $209.00 target price on shares of Procter & Gamble in a report on Friday, December 27th. Wells Fargo & Company reduced their price objective on shares of Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. Evercore ISI lifted their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. Royal Bank of Canada reiterated a “sector perform” rating and issued a $164.00 price target on shares of Procter & Gamble in a research note on Monday, October 21st. Finally, Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective on the stock. in a research report on Monday, September 30th. Eight analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $179.75.
Read Our Latest Analysis on PG
Insider Buying and Selling
In other Procter & Gamble news, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the sale, the chief executive officer now owns 39,977 shares in the company, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the sale, the insider now directly owns 11,566 shares of the company’s stock, valued at $1,954,538.34. This represents a 52.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 75,439 shares of company stock worth $13,317,460 over the last three months. 0.18% of the stock is owned by insiders.
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More
- Five stocks we like better than Procter & Gamble
- ESG Stocks, What Investors Should Know
- 3 Dividend Stocks with Growth Potential You Can’t Miss
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 2 Chinese EV Makers Setting Record Sales and Improving Margins
- Stock Splits, Do They Really Impact Investors?
- Top 3 Preferred Stock ETFs Offering Stability and High Dividends
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.